Basilea's Antibiotic BAL5788 - Unlikely to Induce Resistance in MRSA
05-May-2004 -
Basilea Pharmaceutica AG presented in vitro data at the 14th European Congress on Clinical Microbiology and Infectious Diseases (ECCMID), demonstrating that BAL9141 (the active component of prodrug BAL5788) is unlikely to induce significant resistance in methicillin-resistant Staphyloccus aureus ...
DNA sequencing
infectious diseases
microbiology